EichorEICHOR
Location: Mar Del Plata Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Mar Del Plata

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Phase 3 · Centro de Investigaciones Medicas Mar del Plata · Daiichi Sankyo · NCT07022483A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Phase 2/Phase 3 · Instituto de Investigaciones Clinicas Mar del Plata ( Site 3 · Merck Sharp & Dohme LLC · NCT07266831Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Centro de Investigaciones Medicas Mar del Plata · Amgen · NCT07037433A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena
Phase 3 · Instituto de Investigaciones Clinicas Mar del Plata ( Site 0 · Merck Sharp & Dohme LLC · NCT07216703A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Phase 3 · Instituto de Investigaciones Clínicas Mar del Plata ( Site 0 · Merck Sharp & Dohme LLC · NCT07044297A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · Instituto de Investigaciones Clínicas Mar del Plata ( Site 2 · Merck Sharp & Dohme LLC · NCT06077760A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic So
Phase 1/Phase 2 · Centro de Investigaciones Medicas Mar Del Plata · Daiichi Sankyo · NCT06330064A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-0
Phase 3 · Instituto de Investigaciones Clinicas Mar del Plata ( Site 0 · Merck Sharp & Dohme LLC · NCT07489495A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Phase 2 · Instituto de Investigaciones Clinicas Mar de Plata ( Site 03 · Merck Sharp & Dohme LLC · NCT06833073Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesop
Phase 3 · Centro de Investigaciones Medicas Mar del Plata · Daiichi Sankyo · NCT06731478A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Phase 3 · Imagenes Mdq · Pfizer · NCT06629779A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Livi
Phase 2 · Renalida · Novo Nordisk A/S · NCT06717698A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT
Phase 3 · Instituto de Investigaciones Clínicas Mar del Plata ( Site 0 · Merck Sharp & Dohme LLC · NCT07554339A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type
Phase 3 · Centro de Investigaciones Medicas Mar Del Plata · Hoffmann-La Roche · NCT07351058A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R)
Phase 3 · Instituto de Investigaciones Clínicas Mar del Plata ( Site 1 · Merck Sharp & Dohme LLC · NCT05947851A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
Phase 2 · Instituto de Investigaciones Clínicas Mar del Plata · Eli Lilly and Company · NCT07219173Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in
Phase 3 · Instituto de Investigaciones Clínicas Mar del Plata ( Site 1 · Merck Sharp & Dohme LLC · NCT03486873Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Phase 3 · Instituto de Investigaciones Clínicas Mar del Plata ( Site 0 · Merck Sharp & Dohme LLC · NCT06136624A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vit
Phase 3 · Centro de Investigaciones Medicas Mar Del Plata · Incyte Corporation · NCT06804811A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD
Phase 3 · Centro de Investigaciones Medicas Mar Del Plata · Hoffmann-La Roche · NCT05878769Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Ce
Phase 3 · Instituto de Investigaciones Clínicas Mar del Plata ( Site 0 · Merck Sharp & Dohme LLC · NCT06422143A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Phase 3 · Instituto de Investigaciones Clínicas Mar del Plata ( Site 0 · Merck Sharp & Dohme LLC · NCT07060807A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
Phase 3 · Instituto de Investigaciones Clinicas Mar del Plata ( Site 2 · Merck Sharp & Dohme LLC · NCT07318558Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participa
Phase 3 · Instituto de Investigaciones clinicas de Mar del Plata · Amgen · NCT06252649A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invas
Phase 3 · Basilea Pharmaceutica · NCT05421858A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Phase 3 · Instituto de Investigaciones Clinicas Mar del Plata ( Site 6 · Merck Sharp & Dohme LLC · NCT06966700A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Al
Phase 3 · Instituto de Investigaciones Clínicas Mar del Plata ( Site 0 · Merck Sharp & Dohme LLC · NCT06952504A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Pr
Phase 3 · Instituto de Investigaciones Clinicas Mar del Plata ( Site 0 · Merck Sharp & Dohme LLC · NCT06717347A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who
Phase 2 · Centro de Investigaciones Medicas Mar Del Plata · Hoffmann-La Roche · NCT07137598Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cel
Phase 3 · Gilead Sciences · NCT06801834
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.